Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $40.3095 (2.2%) ($39.3864 - $40.4990) on Tue. Apr. 15, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.31% (three month average) | RSI | 40 | Latest Price | $40.3095(2.2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.4% a day on average for past five trading days. | Weekly Trend | ABBV declines -3.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(62%) SPY(47%) VT(44%) XBI(41%) QQQ(40%) | Factors Impacting ABBV price | ABBV will decline at least -1.155% in a week (0% probabilities). TLT(-15%) UUP(-7%) GLD(-5%) IGOV(-4%) TIP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.155% (StdDev 2.31%) | Hourly BBV | 0 () | Intraday Trend | 0.9% | | | |
|
Resistance Level | $42.49 | 5 Day Moving Average | $40.13(0.45%) | 10 Day Moving Average | $41.55(-2.99%) | 20 Day Moving Average | $42.49(-5.13%) | To recent high | -10% | To recent low | 3% | Market Cap | $71.117b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |